katharine spink  asterias biotherapeutics inc  zoominfocom   katharine spink asterias biotherapeutics inc profile  biography  bloomberg feedback katharine spink exec vpcoo asterias biotherapeutics inc career history exec vpcoo asterias biotherapeutics inc present vpcoo asterias biotherapeutics inc  vpoperations geron corp  senior dircell therepies geron corp  program director geron corp  various positions geron corp  senior vpalliance mgmt geron corp unknown show more website wwwasteriasbiotherapeuticscom corporate information address  dumbarton circle fremont ca  united states phone  fax  web url wwwasteriasbiotherapeuticscom from the web personal information education william marsh rice university bachelors degree biochemistry stanford university phd sponsored financial commentaries more from the web home news top headlines most popular exclusive law entrepreneurs leaders economy environment science sports markets magazine pursuits magazine bloomberg visual data bloomberg best and worst for comments or complaints about news coverage click here regions us china europe asia uk  ireland australia  new zealand canada india  pakistan japan africa eastern europe latin america middle east markets commodities currencies bonds stocks energy markets municipal bonds emerging markets funds islamic finance industries energy technology real estate finance health care transportation insurance retail media manufacturing quick market data stocks stock futures world indexes americas europe middle east  africa asiapacific gainers  losers earnings calendar industry leaders currencies americas europe middle east  africa asiapacific foreign exchange cross rates fx fixings currency converter forex trading videos commodities energy prices metals prices agricultural prices rates  bonds us treasuries uk gilts germany bunds japan bonds australia bonds bloomberg bond indexes corporate bonds consumer rates economic calendar watchlist european debt crisis symbol search the market now personal finance top headlines saving  investing real estate retirement planning financial advisers taxes blog ventured  gained real cost of money gallery calculators watchlist portfolio tracker tech top headlines social media mobile  wireless web enterprise tech tv games  movies apple tech deals global tech slideshows videos us politics sustainability top headlines energy corporate sustainability policy natural resources health  population slideshows videos blog the grid luxury top headlines autos billionaires living property travel well spent loot blog pursuits magazine videos tv live tv channel finder personalities apple tv ipad app schedule us asia europe shows surveillance market makers lunch money street smart bloomberg west game changers video must see latest live tv shows playlist radio live radio shows schedule personalities podcasts bloomberg brief featured podcasts and new shows bloomberg view masters in business first word surveillance bloomberg advantage in the loop bloomberg law taking stock bloomberg best more podcasts blogs global tech the grid loot the market now political capital tech deals ventured and gained opinion my saved registration sign in bloombergcom businessweekcom company about blog careers diversity  inclusion news mission philanthropy  engagement press room procurement sustainability products financial products bloomberg professional service bloomberg anywhere bloomberg tradebook bloomberg briefs bloomberg indexes bloomberg sef service center customer support enterprise products enterprise solutions trading solutions industry products bloomberg bna bloomberg government bloomberg law bloomberg link bloomberg new energy finance bloomberg sports content licensing bloomberg anywhere mobile apps bloomberg visual data katharine e spink phd executive profile  biography  bloomberg july    pm et biotechnology company overview of asterias biotherapeutics inc snapshotpeople  overviewboard memberscommittees executive profile katharine e spink phdexecutive vp and chief operating officer asterias biotherapeutics incagetotal calculated compensationthis person is connected to  board members in  different organizations across  different industriesas of fiscal year  background dr katharine e spink also known as katy phd has been the chief operating officer and executive vice president of asterias biotherapeutics inc since march  and june   respectively dr spink served as vice president of asterias biotherapeutics inc until september   dr spink served as senior vice president of alliance management and cell therapy product development at geron corporation until november  she served as a senior vice president  of operations for cell therapy programs at geron corporation since february  dr spink served as a vice president of operations for regenerative medicine programs at geron corporation from february  to february  from january  to february  dr spink served as a senior director of regenerative medicine program operations at geron corporation from january  to january  dr spink served as program director of cardiovascular disease at geron corporation dr spink joined geron in december  and served various roles within corporate development group until january  prior to joining geron dr spink was a management consultant at mckinsey  company advising clients in the biotechnology pharmaceutical and medical device industries on matters relating to rd strategy business development and marketing dr spink graduated magna cum laude and phi beta kappa with a ba in biochemistry from rice university and received her phd in cancer biology from stanford universityread full background corporate headquarters  dumbarton circlefremont california united statesphone fax  board members memberships there is no board members memberships data available education phd stanford universityba rice university other affiliations geron corporationstanford universityrice university annual compensation salarytotal annual compensation stocks options restricted stock awardsall other compensationexercisable optionsexercisable options valueunexercisable optionsunexercisable options valuetotal value of optionstotal number of options total compensation total annual cash compensationtotal short term compensationother long term compensationtotal calculated compensation request profile update   the information and data displayed in this profile are created and managed by sp global market intelligence a division of sp global bloombergcom does not create or control the content for inquiries please contact sp global market intelligence directly by clicking here stock quotes market data is delayed at least  minutes company lookup competitor compensationthere is no competitor compensation data available sponsored financial commentaries sponsored links browse companies a b c d e f g h i j k l m n o p q r s t u v w x y z              request profile update only a company representative may request an update for the company profile documentation will be required to contact asterias biotherapeutics inc please visit  company data is provided by sp global market intelligence please use this form to report any data issues information missing  please enter your information in the following fields company name your name your email address your phone number type of data overview executives key developments similar companies transactions update needed all data changes require verification from public sources please include the correct value or values and a source where we can verify cancel submit your requested update has been submitted our data partners will research the update request and update the information on this page if necessary research and followup could take several weeks if you have questions you can contact them at bwwebmasterbusinessweekcom close ast katharine e spink insider trades for asterias biotherapeutics inc bulletin trump tweets he has named john kelly new chief of staff » investor alert new york markets after hours market snapshot winners and losers expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close asterias biotherapeutics inc nyse american ast go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus asterias biotherapeutics inc after hours  quotes are delayed by  min jul    pm ast quoteszigmancomposite   change   volume volume  quotes are delayed by  min quoteszigmancomposite todays close     change   day low day high    week low  week high   insider activity individual katharine e spink dr katharine e spink is chief operating officer  vice president at asterias biotherapeutics inc dr spink was previously employed as senior vpalliance management  operations by geron corp she received her undergraduate degree from rice university and a doctorate degree from the stanford university school of medicine transactions date shares transaction value     derivativenonderivative trans at  per share      award at  per share      disposition at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share      disposition at  per share      disposition at  per share      award at  per share      disposition at  per share      derivativenonderivative trans at  per share  copyright  factset research systems inc all rights reserved source factset fundamentals officers and executives mr michael h mulroy president  chief executive officer dr katharine e spink chief operating officer  vice president mr ryan d chavez cfo secretary  general counsel dr jane s lebkowski chief scientific officer dr edward d wirth chief medical officer mr aditya p mohanty director dr michael d west director mr alfred dennis kingsley director mr frank lanza vice president  controller mr don matthew bailey nonexecutive chairman dr howard i scher independent director mr andrew arno independent director mr natale s ricciardi independent director mr richard towne lebuhn independent director trending tickers quoteszigmancomposite vuzi quoteszigmancomposite jcp quoteszigmancomposite nugt quoteszigmancomposite jnug quoteszigmancomposite tlt x powered by log in  pm edt july   marketstatecountryus new york after marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest pwall street isn’t ready for a point tumble in the dow industrials pbreakingin a tweet trump names gen kelly his new chief of staff pmattel could get wrecked by weak ‘cars ’ toy sales pthis  number sums up why that foxconn deal is overthetop bad for wisconsin pbreakingtrump tweets hes named a new chief of staff john kelly pwall street isn’t ready for a point tumble in the dow industrials plongdated treasury yields see weekly climb psp  nasdaq finish lower after amazon disappointment dow closes at record pthe highest paid athletes in the world in one chart phow to raise your kids to be frugal but not too frugal pcities to move to if you want to work in tech — not including san francisco pwhat donald trump’s battle of wills with jeff sessions teaches you about a difficult boss pone way you’re paying creditcard fees even if you don’t have a card ptrump russia and sanctions what we know pthis is the worst mistake people make at work pmove over breathalyzers ‘textalyzers’ could be used on drivers’ phones pjared kushner’s unorthodox approach to meetings is a cautionary tale for office workers everywhere phere’s how much you should spend on a yoga mat p weird things i found out about america in my first  hours pweekend sip is this the world’s first distilled nonalcoholic spirit loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  ast key statistics  asterias biotherapeutics inc financial ratios  marketwatch bulletin trump tweets he has named john kelly new chief of staff » investor alert new york markets after hours market snapshot winners and losers expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close asterias biotherapeutics inc nyse american ast go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus asterias biotherapeutics inc after hours  quotes are delayed by  min jul    pm ast quoteszigmancomposite   change   volume volume  quotes are delayed by  min quoteszigmancomposite todays close     change   day low day high    week low  week high   company description asterias biotherapeutics inc is a clinicalstage biotechnology company which is focused on developing and commercializing novel therapies in the emerging fields of cell therapy and regenerative medicine the company is also focused on developing therapies to treat conditions with unmet medical ne asterias biotherapeutics inc is a clinicalstage biotechnology company which is focused on developing and commercializing novel therapies in the emerging fields of cell therapy and regenerative medicine the company is also focused on developing therapies to treat conditions with unmet medical needs and inadequate available therapies with an initial focus on the therapeutic areas of oncology and neurology its product candidates include astopc trial for spinal cord injuries astvac a patient specific cancer immunotherapy focused on acute myeloid leukemia and astvac a nonpatientspecific cancer immunotherapy for nonsmall cell lung cancer the company was founded on september   and is headquartered in fremont ca valuation pe current  pe ratio with extraordinary items  price to sales ratio  price to book ratio  enterprise value to ebitda  enterprise value to sales  total debt to enterprise value  efficiency revenueemployee  income per employee  receivables turnover  total asset turnover  liquidity current ratio  quick ratio  cash ratio  profitability gross margin  operating margin  pretax margin  net margin  return on assets  return on equity  return on total capital  return on invested capital  capital structure total debt to total equity  total debt to total capital  total debt to total assets  longterm debt to equity  longterm debt to total capital  officers and executives name age officer since title mr michael h mulroy   president  chief executive officer dr katharine e spink   chief operating officer  vice president mr ryan d chavez   cfo secretary  general counsel dr jane s lebkowski   chief scientific officer dr edward d wirth   chief medical officer insider actions – purchase – sale  – number of transactions  × manage bookmarks close feedback